首页>
外国专利>
SWERTISIN AS POTENT AND NOVEL MOLECULE FOR ISLET DIFFERENTIATION FROM HUMAN BONE MARROW DERIVED MESENCHYMAL STEM CELLS
SWERTISIN AS POTENT AND NOVEL MOLECULE FOR ISLET DIFFERENTIATION FROM HUMAN BONE MARROW DERIVED MESENCHYMAL STEM CELLS
展开▼
机译:威斯汀作为强力和新颖分子可从人骨髓间充质干细胞分化为胰岛
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides a novel therapeutic characteristic method describing Swertisins potential in islet differentiation /islet neogenesis along with cellular homing. More specifically the present invention relates to step wise differentiation of human and mouse bone marrow derived mesenchymal stem cells into functional, efficient, and cost-effective islet like clusters using specific differentiation media. The invention also describes an in vivo functionality of isletlike cell clusters in ameliorating the diabetic condition streptozotocin diabetic mouse model. Further, Swertisin enhances homing of mouse bone marrow derived mesenchymal stem cells towards the damaged pancreas and stimulate to differentiate into functional insulin producing cells. Thus, present invention relates to methods of treating diabetes.
展开▼